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Bone morphogenetic protein 2 released slowly from a gelatin sponge induced cartilage
regeneration in a canine tracheal cartilage defect model. The regenerated cartilage was strong
enough to maintain the tracheal internal lumen for more than 6 months.
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335 Bronchoscopic surfactant administration preserves gas exchange and
pulmonary compliance after single lung transplantation in dogs
Ivar Friedrich, MD, Jochen Bo¨rgermann, MD, Fred H. Splittgerber, MD, Matthias Brinkmann,
MD, J. Christoph Reidemeister, MD, Rolf E. Silber, MD, Werner Seeger, MD,
Reinhold Schmidt, PhD, and Andreas Gu¨nther, MD, Halle, Essen, and Giessen, Germany
The effect of bronchoscopic surfactant administration was evaluated in a canine model of
heterologous left lung transplantation (24-hour storage, 12-hour reperfusion). We conclude that
surfactant administration does not prevent leukocyte influx and vascular leakage but does
protect against respiratory failure and improves lung mechanics.
344 Surfactant abnormalities after single lung transplantation in dogs: Impact of
bronchoscopic surfactant administration
Andreas Gu¨nther, MD, Markus Balser, MD, Reinhold Schmidt, PhD, Philipp Markart, MD,
Alexander Olk, MD, Jochen Bo¨rgermann, MD, Fred H. Splittgerber, MD, Werner Seeger, MD,
and Ivar Friedrich, MD, Giessen, Halle, and Essen, Germany
Severe compositional and functional surfactant abnormalities occur exclusively in grafts in dog
single lung transplantation when performing separate, synchronized ventilation of each lung to
attenuate ventilator-induced lung injury. Bronchoscopic surfactant administration provides
protection against these abnormalities and may be a therapeutic strategy in lung transplantation.
355 Augmenting major histocompatibility complex class I expression by murine
tumors in vivo enhances antitumor immunity induced by an active
immunotherapy strategy
Robert E. Merritt, MD, Reiko E. Yamada, BA, Ronald G. Crystal, MD, and
Robert J. Korst, MD, New York, NY
Interferon-gamma augments major histocompatibility complex class I expression by B16.F10
murine tumors, enhancing the antitumor effects and cure rate of a CD8 T-lymphocyte–
mediated immunotherapy strategy. The generation of tumor-specific cytotoxic T lymphocytes
and their ability to bind to and become activated by tumor cells are augmented in this model.
Class I blockade attenuates these synergistic effects.
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